mrtx849
Showing 1 - 10 of 10
Colon Cancer, Colorectal Cancer Trial in Houston (MRTX849, Irinotecan, Cetuximab)
Not yet recruiting
- Colon Cancer
- Colorectal Cancer
- MRTX849
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 1, 2023
Metastatic Pancreatic Cancer Trial in Houston (MRTX849)
Not yet recruiting
- Metastatic Pancreatic Cancer
- MRTX849
-
Houston, TexasM D Anderson Cancer Center
Nov 22, 2022
Advanced or Metastatic Solid Tumor Trial in China (MRTX849)
Recruiting
- Advanced or Metastatic Solid Tumor
- MRTX849
-
Beijing, Beijing, China
- +9 more
Jun 9, 2022
Advanced Cancer, Metastatic Cancer, Malignant Tumor of Colon Trial in United States (MRTX849, BI 1701963)
Active, not recruiting
- Advanced Cancer
- +4 more
- MRTX849
- BI 1701963
-
Saint Louis, Missouri
- +3 more
Apr 4, 2022
Advanced Cancer, Metastatic Cancer, Malignant Neoplastic Disease Trial in United States (MRTX849, TNO155)
Active, not recruiting
- Advanced Cancer
- +2 more
- MRTX849
- TNO155
-
Los Angeles, California
- +11 more
Nov 12, 2021
Metastatic Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer Trial in Worldwide (MRTX849, Docetaxel)
Recruiting
- Metastatic Non Small Cell Lung Cancer
- Advanced Non Small Cell Lung Cancer
- MRTX849
- Docetaxel
-
Santa Rosa, California
- +141 more
Aug 10, 2022
Advanced Cancer, Metastatic Cancer, Malignant Neoplastic Disease Trial in Puerto Rico, United States (MRTX849, Pembrolizumab,
Recruiting
- Advanced Cancer
- +2 more
- MRTX849
- +3 more
-
Birmingham, Alabama
- +97 more
Jan 6, 2023
Advanced Colorectal Cancer, Metastatic Colorectal Cancer Trial in Worldwide (MRTX849, Cetuximab, mFOLFOX6 Regimen)
Recruiting
- Advanced Colorectal Cancer
- Metastatic Colorectal Cancer
- MRTX849
- +3 more
-
Birmingham, Alabama
- +208 more
Aug 3, 2022